US green light for Remicade biosimilar
admin 24th April 2017 Uncategorised 0US regulators have approved Renflexis, a biosimilar referencing Johnson & Johnson’s tumour necrosis factor (TNF) blocker Remicade (infliximab), across all eligible indications.
More: US green light for Remicade biosimilar
Source: News